These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11340074)

  • 1. Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis.
    Zhu Q; Yao J; Wani G; Wani MA; Wani AA
    J Biol Chem; 2001 Aug; 276(32):29695-701. PubMed ID: 11340074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyubiquitination of p53 by a ubiquitin ligase activity of p300.
    Grossman SR; Deato ME; Brignone C; Chan HM; Kung AL; Tagami H; Nakatani Y; Livingston DM
    Science; 2003 Apr; 300(5617):342-4. PubMed ID: 12690203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of p53 degradation by Mdm2 acetylation.
    Wang X; Taplick J; Geva N; Oren M
    FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization and activation of p53 by the coactivator protein TAFII31.
    Buschmann T; Lin Y; Aithmitti N; Fuchs SY; Lu H; Resnick-Silverman L; Manfredi JJ; Ronai Z; Wu X
    J Biol Chem; 2001 Apr; 276(17):13852-7. PubMed ID: 11278372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p300/MDM2 complexes participate in MDM2-mediated p53 degradation.
    Grossman SR; Perez M; Kung AL; Joseph M; Mansur C; Xiao ZX; Kumar S; Howley PM; Livingston DM
    Mol Cell; 1998 Oct; 2(4):405-15. PubMed ID: 9809062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation.
    Jin Y; Zeng SX; Lee H; Lu H
    J Biol Chem; 2004 May; 279(19):20035-43. PubMed ID: 14769800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 suppresses p73 function without promoting p73 degradation.
    Zeng X; Chen L; Jost CA; Maya R; Keller D; Wang X; Kaelin WG; Oren M; Chen J; Lu H
    Mol Cell Biol; 1999 May; 19(5):3257-66. PubMed ID: 10207051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2.
    Maki CG
    J Biol Chem; 1999 Jun; 274(23):16531-5. PubMed ID: 10347217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
    Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT
    Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation.
    Zhou BP; Liao Y; Xia W; Zou Y; Spohn B; Hung MC
    Nat Cell Biol; 2001 Nov; 3(11):973-82. PubMed ID: 11715018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function.
    Thomas A; White E
    Genes Dev; 1998 Jul; 12(13):1975-85. PubMed ID: 9649502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination.
    Nie L; Sasaki M; Maki CG
    J Biol Chem; 2007 May; 282(19):14616-25. PubMed ID: 17371868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding.
    Inoue T; Geyer RK; Howard D; Yu ZK; Maki CG
    J Biol Chem; 2001 Nov; 276(48):45255-60. PubMed ID: 11572869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300.
    O'Connor MJ; Zimmermann H; Nielsen S; Bernard HU; Kouzarides T
    J Virol; 1999 May; 73(5):3574-81. PubMed ID: 10196247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2-dependent ubiquitination of nuclear and cytoplasmic P53.
    Yu ZK; Geyer RK; Maki CG
    Oncogene; 2000 Nov; 19(51):5892-7. PubMed ID: 11127820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression.
    Wadgaonkar R; Collins T
    J Biol Chem; 1999 May; 274(20):13760-7. PubMed ID: 10318779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.
    Nakamura S; Roth JA; Mukhopadhyay T
    Mol Cell Biol; 2000 Dec; 20(24):9391-8. PubMed ID: 11094089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter specificity and stability control of the p53-related protein p73.
    Lee CW; La Thangue NB
    Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.
    Knights CD; Liu Y; Appella E; Kulesz-Martin M
    J Biol Chem; 2003 Dec; 278(52):52890-900. PubMed ID: 14555661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
    Grönroos E; Terentiev AA; Punga T; Ericsson J
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.